ARK ETF TR - GENOMIC REV ETF (ARKG)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / GENOMIC REV ETF
Total 13F shares
9,170,973
Share change
+3,745,835
Total reported value
$478,909,682
Price per share
$52.16
Number of holders
162
Value change
+$200,541,364
Number of buys
128
Number of sells
25

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2020

As of 30 Jun 2020 ARK ETF TR - GENOMIC REV ETF (ARKG) had 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 9,170,973 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, UBS Group AG, Carroll Financial Associates, Inc., MAINSTAY CAPITAL MANAGEMENT LLC /ADV, LPL Financial LLC, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, COMMONWEALTH EQUITY SERVICES, LLC, Claraphi Advisory Network, LLC, and Legend Financial Advisors, Inc..
This table shows 162 institutional shareholders of the security as of 30 Jun 2020.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.